LPTX logo

Leap Therapeutics, Inc. (LPTX)

Profile

Full Name

Leap Therapeutics, Inc.

Ticker

NASDAQ: LPTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 25, 2017

Indexes

Not included

Website

https://www.leaptx.com

Employees

24

Key Details

Price

$0.53(-26.85%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$1.81(54.66% YoY)

PE Ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.53
    LPTX price is $0.53

    30-Day Relative Volume

    4.31
    LPTX 30-day relative volume is 4.31

    Price Performance

    Price Most Recent Change

    -26.85%
    LPTX price was down -26.85% on Oct 3, 2025

    Price YTD Change

    -81.43%
    LPTX price is down -81.43% since January 1st

    Price 1-Year Change

    -78.38%
    LPTX price is down -78.38% year-on-year

    Price 3-Year Change

    -94.05%
    LPTX price is down -94.05% over the past 3 years

    Price Range

    Price All-Time High

    $102.50
    LPTX price is currently -99.48% below its historical high of $102.50

    Price 3-Year Low

    $0.22
    LPTX price is currently +140.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $22.13M
    LPTX market cap is $22.13 million

    Market Cap 3-Year Change

    -75.11%
    LPTX market cap is down -75.11% over the past 3 years

    Market Cap All-Time High

    $352.23M
    LPTX market cap is currently -93.72% below its historical high of $352.23 million

    Market Cap Sector Percentile

    22.81%
    LPTX market cap is higher than 22.81% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +8.3%
    LPTX shares outstanding is up +8.3% year-on-year

    Shares Outstanding 3-Year Change

    +318.49%
    LPTX shares outstanding is up +318.49% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.41
    LPTX beta is 1.41

    200-day SMA

    $0.71
    LPTX price is currently -25.22% below its 200-day simple moving average

    50-day SMA

    $0.33
    LPTX price is currently +63.35% above its 50-day simple moving average

    14-Day RSI

    62.96
    LPTX 14-day relative strength index is 62.96

    Volume

    4.31
    LPTX 30-day relative volume is 4.31

    ATR

    $0.08
    LPTX average true range is $0.08

    10-day Historical Volatility

    280.69%
    LPTX 10-day historical volatility is 280.69%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    LPTX annual revenue is $0.00

    Revenue Analysts Estimate

    -
    LPTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    LPTX annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.74%
    LPTX annual revenue is higher than 28.74% of companies in Healthcare sector

    EPS

    EPS

    -$1.81
    LPTX annual earnings per share is -$1.81

    EPS Analysts Estimate

    -$1.11
    LPTX annual earnings per share is currently +62.64% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +54.66%
    LPTX annual earnings per share is up +54.66% year-on-year

    EPS Sector Percentile

    40.42%
    LPTX annual earnings per share is higher than 40.42% of companies in Healthcare sector

    Profit

    Gross Profit

    -$5000.00
    LPTX annual gross profit is -$5000.00

    Gross Margin

    -
    LPTX annual gross profit margin value is unknown

    Operating Profit

    -$70.06M
    LPTX annual operating income is -$70.06 million

    Operating Margin

    -
    LPTX annual operating profit margin value is unknown

    Net Income

    -$67.56M
    LPTX annual net profit is -$67.56 million

    Net Margin

    -
    LPTX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $70.06M
    LPTX annual total expenses is $70.06 million

    Operating Expenses

    $70.06M
    LPTX annual total operating expenses is $70.06 million

    Cost Of Goods Sold

    $5000.00
    LPTX annual cost of goods sold is $5000.00

    Selling, General & Administrative Expenses

    $12.85M
    LPTX annual SG&A is $12.85 million

    Depreciation & Amortization

    $5000.00
    LPTX annual D&A is $5000.00

    Interest Expense

    $0.00
    LPTX annual interest expense is $0.00

    Income Tax

    $585.00K
    LPTX annual income tax is $585.00 thousand

    EBIT & EBITDA

    EBIT

    -$70.06M
    LPTX annual earnings before interest & taxes is -$70.06 million

    EBITDA

    -$70.05M
    LPTX annual EBITDA is -$70.05 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $49.12M
    LPTX annual total assets is $49.12 million

    Non Current Assets

    $1.08M
    LPTX annual long term assets is $1.08 million

    Current Assets

    $48.04M
    LPTX annual total current assets is $48.04 million

    Cash and Cash Equivalents

    $47.25M
    LPTX annual cash & cash equivalents is $47.25 million

    Accounts Receivable

    -
    LPTX annual accounts receivable value is unknown

    Inventory

    $0.00
    LPTX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $14.08M
    LPTX annual total liabilities is $14.08 million

    Long Term Liabilities

    $0.00
    LPTX annual total long term liabilities is $0.00

    Current Liabilities

    $14.08M
    LPTX annual current liabilities is $14.08 million

    Accounts Payable

    $4.74M
    LPTX annual accounts payable is $4.74 million

    Debt

    Total Debt

    $266.00K
    LPTX annual total debt is $266.00 thousand

    Total Debt 1-Year Change

    +1.53%
    LPTX annual total debt is up +1.53% year-on-year

    Long Term Debt

    $0.00
    LPTX annual long term debt is $0.00

    Short Term Debt

    $266.00K
    LPTX annual short term debt is $266.00 thousand

    Equity & Capital

    Shareholders Equity

    $35.05M
    LPTX annual stockholders equity is $35.05 million

    Book Value

    $35.05M
    LPTX annual book value is $35.05 million

    Retained Earnings

    -$467.37M
    LPTX annual retained earnings is -$467.37 million

    Working Capital

    $33.96M
    LPTX annual working capital is $33.96 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$60.30M
    LPTX annual cash from operations is -$60.30 million

    Cash From Operations 1-Year Change

    -37.82%
    LPTX annual cash from operations is down -37.82% year-on-year

    Cash From Investing

    $0.00
    LPTX annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    -100%
    LPTX annual cash from investing is down -100% year-on-year

    Cash From Financing

    $37.18M
    LPTX annual cash from financing is $37.18 million

    Cash From Financing 1-Year Change

    +124046.67%
    LPTX annual cash from financing is up +124046.67% year-on-year

    CAPEX

    CAPEX

    $0.00
    LPTX annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    LPTX annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$60.30M
    LPTX annual free cash flow is -$60.30 million

    Free Cash Flow 1-Year Change

    -37.82%
    LPTX annual free cash flow is down -37.82% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    LPTX annual gross profit margin value is unknown

    Operating Margin

    -
    LPTX annual operating profit margin value is unknown

    Net Margin

    -
    LPTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -110.79%
    LPTX annual return on assets is -110.79%

    ROE

    -141.94%
    LPTX annual return on equity is -141.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    LPTX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    LPTX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    3.87
    LPTX price to book ratio is 3.87

    PB Ratio Sector Percentile

    69.79%
    LPTX price to book ratio is higher than 69.79% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    LPTX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    LPTX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $4.28M
    LPTX enterprise value is $4.28 million

    Enterprise Value Sector Percentile

    15.04%
    LPTX enterprise value is higher than 15.04% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.07
    LPTX EV/EBITDA is -0.07

    EV/EBITDA Sector Percentile

    64.27%
    LPTX EV/EBITDA is higher than 64.27% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.41
    LPTX annual current ratio is 3.41

    Quick Ratio

    3.41
    LPTX annual quick ratio is 3.41

    Leverage

    Debt To Equity

    0.01
    LPTX annual debt to equity ratio is 0.01

    Interest Coverage Ratio

    -
    LPTX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    LPTX piotroski f-score value is unknown

    Altman Z-Score

    -16.25
    LPTX altman z-score is -16.25

    Analyst ratings

    Recent major analysts updates

    Mar 27, 25 HC Wainwright & Co.
    Neutral
    Jan 16, 25 HC Wainwright & Co.
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Aug 13, 24 HC Wainwright & Co.
    Buy
    Jun 28, 24 Rodman & Renshaw
    Buy
    May 14, 24 HC Wainwright & Co.
    Buy
    Mar 19, 24 HC Wainwright & Co.
    Buy
    Mar 19, 24 Baird
    Outperform
    Nov 20, 23 Mizuho
    Buy
    Nov 14, 23 Raymond James
    Outperform

    Institutional Ownership

    Screeners with LPTX included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    • What is the ticker symbol for Leap Therapeutics, Inc.?
    • Does Leap Therapeutics, Inc. pay dividends?
    • What sector is Leap Therapeutics, Inc. in?
    • What industry is Leap Therapeutics, Inc. in?
    • What country is Leap Therapeutics, Inc. based in?
    • When did Leap Therapeutics, Inc. go public?
    • Is Leap Therapeutics, Inc. in the S&P 500?
    • Is Leap Therapeutics, Inc. in the NASDAQ 100?
    • Is Leap Therapeutics, Inc. in the Dow Jones?
    • When was Leap Therapeutics, Inc.'s last earnings report?
    • When does Leap Therapeutics, Inc. report earnings?

    What is the ticker symbol for Leap Therapeutics, Inc.?

    The ticker symbol for Leap Therapeutics, Inc. is NASDAQ:LPTX

    Does Leap Therapeutics, Inc. pay dividends?

    No, Leap Therapeutics, Inc. does not pay dividends

    What sector is Leap Therapeutics, Inc. in?

    Leap Therapeutics, Inc. is in the Healthcare sector

    What industry is Leap Therapeutics, Inc. in?

    Leap Therapeutics, Inc. is in the Biotechnology industry

    What country is Leap Therapeutics, Inc. based in?

    Leap Therapeutics, Inc. is headquartered in United States

    When did Leap Therapeutics, Inc. go public?

    Leap Therapeutics, Inc.'s initial public offering (IPO) was on January 25, 2017

    Is Leap Therapeutics, Inc. in the S&P 500?

    No, Leap Therapeutics, Inc. is not included in the S&P 500 index

    Is Leap Therapeutics, Inc. in the NASDAQ 100?

    No, Leap Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Leap Therapeutics, Inc. in the Dow Jones?

    No, Leap Therapeutics, Inc. is not included in the Dow Jones index

    When was Leap Therapeutics, Inc.'s last earnings report?

    Leap Therapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does Leap Therapeutics, Inc. report earnings?

    The next expected earnings date for Leap Therapeutics, Inc. is November 12, 2025
    On this page